Sickle cell disease: open trials in Belgium

12 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT07224360
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Trial Treatment · Phase 2 · CSL Behring
CHU Saint-Pierre, Brussels · Universitair Ziekenhuis Antwerpen, Edegem
Registry updated 2026-11-03
NCT05777993
A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study
Trial Treatment · Phase 4 · Agios Pharmaceuticals, Inc.
Hopital Erasme, Anderlecht
Registry updated 2026-10-28
NCT07656415
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
Trial Treatment · Phase 3 · Agios Pharmaceuticals, Inc.
Hopital Erasme, Anderlecht · Ziekenhuis Aan De Stroom, Antwerp · Centre Hospitalier Regional de la Citadelle, Liège · CHC MontLégia, Liège
Registry updated 2026-10-28
NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Trial Treatment · Phase 3 · Sanofi
Brussels · Brussels · Leuven · Liège
Registry updated 2026-10-15
NCT06699849
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Trial Treatment · Phase 2 · CSL Behring
Hopital Erasme, Anderlecht · Antwerp University Hospital, Edegem · UZ Leuven, Leuven · Centre Hospitalier Regional de la Citadelle, Liège
Registry updated 2026-10-08
NCT06612268
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Trial Treatment · Phase 3 · Novo Nordisk A/S
Hopital Erasme, Anderlecht · Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · CHU Saint-Pierre, Brussels · Universitair Ziekenhuis Antwerpen, Edegem · Antwerp University Hospital, Edegem · UZ Leuven, Leuven
Registry updated 2026-09-17
2024-511410-20-01
A Study to Learn How Different Manufactured Products of the Study Medicine Called Osivelotor (PF-07940367) Taste and Are Taken Up Into the Blood When Mixed With Soft Foods or Liquids Given on an Empty Stomach or Given With Food or an Acid Reducing Agent in Healthy Adults
Trial Treatment · Phase 1 · Pfizer Inc.
Pfizer Clinical Research Unit, Brussels
Registry updated 2026-09-07
NCT05431088
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Trial Treatment · Phase 2/3 · Pfizer
CHU Brugmann, Brussels · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-08-18
NCT04208529
A Long-term Follow-up Study in Participants Who Received CTX001
Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels
Registry updated 2026-08-11
NCT04657822
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Centre Hospitalier Regional de la Citadelle, Liège
Registry updated 2026-06-08
2025-523777-41-01
Morphine PCA vs Morphine and Lidocaine PCA for the treatment of vaso-occlusive crisis-related pain in sickle-cell anaemia patients: a prospective, randomized, double blind monocentric trial.
Trial Treatment · Phase 4 · CHU Saint Pierre
CHU Saint-Pierre, Brussels
Registry updated 2026-01-26
NCT05799118
Study of the Role of Genetic Modifiers in Hemoglobinopathies
Research · Cyprus Institute of Neurology and Genetics
University Hospitals Leuven, Leuven
Registry updated 2024-03-20

All Sickle cell disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error